|
Originally published In Press as doi:10.1074/jbc.M005147200 on August 18, 2000
J. Biol. Chem., Vol. 275, Issue 45, 34968-34975, November 10, 2000
Identification and Characterization of an Equilibrium
Intermediate in the Unfolding Pathway of an All -Barrel Protein*
Dharmaraj
Samuel,
Thallampuranam Krishnaswamy Suresh
Kumar,
Thiagarajan
Srimathi,
Hui-chu
Hsieh, and
Chin
Yu
From the Department of Chemistry, National Tsing Hua University,
Hsinchu, 30043 Taiwan
Received for publication, June 14, 2000, and in revised form, August 11, 2000
 |
ABSTRACT |
The guanidinium hydrochloride (GdnHCl)-induced
unfolding of an all -sheet protein, the human acidic fibroblast
growth factor (hFGF-1), is studied using a variety of biophysical
techniques including multidimensional NMR spectroscopy. The unfolding
of hFGF-1 in GdnHCl is shown to involve the formation of a stable equilibrium intermediate. Size exclusion chromotagraphy using fast
protein liquid chromatography shows that the intermediate accumulates maximally at 0.96 M GdnHCl.
1-Anilinonapthalene 8-sulfonate binding, one-dimensional 1H
NMR, and limited proteolytic digestion experiments suggest that the
intermediate has characteristics resembling a molten globule state.
Chemical shift perturbation and hydrogen-deuterium exchange monitored
by 1H-15N heteronuclear single quantum
coherence spectra reveal that profound structural changes in the
intermediate state (in 0.96 M GdnHCl) occur in the
C-terminal, heparin binding region of the protein molecule.
Additionally, results of the stopped flow fluorescence experiments
suggest that the kinetic refolding of hFGF-1 proceeds through the
accumulation of an intermediate at low concentrations of the
denaturant. To our knowledge, the present study is the first report
wherein an equilibrium intermediate is characterized in detail in an
all -barrel protein.
 |
INTRODUCTION |
There is increasing evidence that the refolding of monomeric
proteins in vitro proceeds along pathways involving the
formation of partially folded, intermediate states (1).
Characterization of the intermediate states is central to the
understanding of protein stability and folding. Such intermediate
states will provide useful information on the range of contexts in
which the same amino acid sequence will fold into a stable structure
and should reveal which interactions are driving the folding process
(2-5).
The molten globule (MG)1 is a
well known example of a partially folded equilibrium state (6-10). MG
states have been proposed to be involved in a number of physiological
processes, such as protein recognition by chaperones, release of
protein ligands, and protein translocation across bio-membranes (11).
Generally, proteins in vitro can be transformed into the MG
state at low pH or in moderate concentrations of the chemical
denaturants or at high temperatures (10, 12). Although MG states have
been identified and characterized in the folding/unfolding pathways of
several proteins, most of these proteins belong to structural class of
all or + (1). Interestingly, there are only few examples
wherein proteins belonging to the all -sheet class are shown to
exist in a MG state(s) (7, 13-18).
In all known structures of the all -barrel type, the -sheet is
twisted to form a -barrel, such that the last -strand is hydrogen
bonded to the first one. Many of the members belonging to the all
-barrel structural class are known to be involved in the regulation
of key cellular processes (19). However, very little information exists
on the folding pathways of these proteins. In an attempt to fill this
lacuna, in the present study, we have embarked on understanding the
equilibrium unfolding pathway of the human acidic fibroblast growth
factor (hFGF-1).
hFGF-1 is a 16-kDa, all -sheet, heparin-binding protein that is
involved in a wide array of cellular processes regulating cell
proliferation (20). hFGF-1 is devoid of disulfide bonds and possesses a
single tryptophan residue, which could be effectively used as a probe
to monitor the conformational changes occurring in the protein under
various physical conditions. The secondary structural elements in the
protein include 12 -strands arranged antiparallely into a -barrel
structure (Fig. 1 and Refs. 21 and 22).
All these structural features render hFGF-1 as a paradigm to understand
the folding/unfolding pathways of all -barrel proteins.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 1.
MOLSCRIPT representation of the structure of
hFGF-1. The secondary structural elements in the protein include
12 -strands arranged into a -barrel. The C-terminal segment
(residues 105-140) constitutes the heparin binding site in the
protein. The arrowheads indicate the various -strands in
the protein.
|
|
In the present study, using various biophysical techniques including
multidimensional NMR spectroscopy, we identify and characterize, a
stable intermediate state in the GdnHCl-induced unfolding pathway of
hFGF-1. To our knowledge, this study represents the first report of a
detailed structural characterization of an equilibrium intermediate in
the unfolding pathway of an all -barrel protein.
 |
MATERIALS AND METHODS |
Heparin-Sepharose was obtained from Amersham Pharmacia Biotech.
Labeled 15NH4Cl was purchased from Cambridge
Isotope Laboratories. Ultrapure urea and GdnHCl were purchased from
Sigma. All other chemical used were of high quality analytical grade.
Unless otherwise mentioned, all solutions were made in 100 mM phosphate buffer (pH 7.0) containing 100 mM
of ammonium sulfate. All experiments were performed at 20 °C.
Protein Expression and Purification--
Residues are numbered
as per their position in the primary structure of the 154-amino acid
hFGF-1. Expression vector for the truncated form of the human FGF-1
(hFGF-1, residues 15-154) was constructed and inserted between the
NdeI and BamHI restriction sites in pET20b. The
plasmid containing the hFGF-1 insert was transformed into
Escherichia coli BL21(DE3)pLysS. The expressed protein was
purified on heparin-Sepharose column using a NaCl gradient (0-1.5
M). The protein was desalted by ultra filtration using an
Amicon set-up. The homogeneity of the protein was assessed using
SDS-PAGE. The authenticity of the sample was further verified by
electron spray mass analysis. The concentration of the protein was estimated from the extinction co-efficient value of the protein at
280 nm.
Preparation of Isotope-enriched hFGF-1--
Uniform
15N isotope labeling was achieved using M9 minimal medium
containing 15NH4Cl. To realize maximal
expression yields, the composition of the M9 medium was modified by the
addition of a mixture mixture of vitamins. The expression host strain
E. coli. BL21(DE3)pLysS is a vitamin
B1-deficient host, and hence the medium was supplemented with thiamine (vitamin B1). Protein expression yields were
in the range of 25-30 mg/liter of the isotope enriched medium. The extent of 15N labeling was verified by electron
spray mass analysis.
Steady State Fluorescence Measurements--
All fluorescence
spectra were collected on a Hitachi F-2500 spectrofluorimeter at 2.5- or 10-nm resolution, using an excitation wavelength of 280 nm.
Intrinsic fluorescence measurements were made at a protein
concentration of 100 µg/ml. ANS binding affinity to hFGF-1 at various
concentrations of the denaturant was monitored with the excitation
wavelength set at 390 nm. The emission was monitored between 450 and
600 nm. The excitation and emission bandwidths were set at 5 nm. The
concentration of the dye (ANS) and the protein used were 200 and 1 µM, respectively.
Circular Dichroism--
All CD measurements were made on a Jasco
J-720 spectropolarimeter using a 0.1-cm-pathlength quartz cell. Each
spectrum was an average of five scans. The concentration of the protein
used was 0.5 mg/ml. Necessary background corrections were made in all spectra.
Equilibrium Unfolding and Data Analysis--
Equilibrium
unfolding data obtained were converted to plots of
Fu, fractions of the protein in the unfolded
state, versus denaturant concentration using the following equation.
|
(Eq. 1)
|
where XD is the value of the
spectroscopic property measured at denaturant concentration ([D]).
XF and XU represent
intercepts, and mF and mU
are the slopes of the folded and unfolded base lines of the data,
respectively, and were obtained from the linear least square fits of
the base lines. In the case of urea-induced unfolding, a two-state
(folded unfolded) transition was assumed, and the free energy of
unfolding by the denaturant (Gu) at
concentration ([D]) is related to FU by
transformation of the Gibbs-Helmholtz equation. It is assumed that the
free energy of unfolding, Gu, has a linear
dependence on the concentration of the denaturant ([D]).
|
(Eq. 2)
|
where G(H2O) and m are the
intercept and slope, respectively, in the plot of
Gu versus concentration of the
denaturant. m is the measure of the co-operativity of the
unfolding reaction and G(H2O) is the
difference in the free energy between the folded and unfolded states of
the protein in the absence of any denaturant.
Size Exclusion Chromatography--
All gel filtration
experiments were carried out at 25 °C on a superdex-100 column using
a AKTA FPLC device (Amersham Pharmacia Biotech). The column was
equilibrated with 2 bed volumes of the buffer (10 mM
phosphate buffer (pH 7.2) containing 100 mM of ammonium sulfate) containing appropriate concentrations of GdnHCl. The flow rate
of the eluent was set at 1 ml/min. Protein peaks were detected by their
280 nm absorbance. The concentration of the protein used was about 1 mg/ml.
Stopped Flow Fluorescence--
Kinetic measurements of protein
refolding or unfolding were performed using a SF-61 stopped flow
spectrofluorimeter (Hi-Tech Scientific Co). For measuring changes in
the intrinsic tryptophan fluorescence (of Trp121) at
different concentrations of GdnHCl, an excitation wavelength of 280 nm
was routinely used with a monochromater slit width of 4 nm. All folding
and unfolding reactions were performed at 25 °C. Unfolding reactions
involved mixing of hFGF-1 with 10-fold excess of GdnHCl to yield a
final protein concentration of about 1.0 µM. The kinetics
associated with refolding involved mixing one volume of unfolded
protein with 10 volumes of the refolding buffer (100 mM
phosphate buffer (pH 7.2) containing 100 mM of ammonium sulfate).
The kinetics data were analyzed by plotting the refolding and unfolding
rates as a function of denaturant concentration in semilogarithmic
plots (Chevron plots) as per the following equations.
|
(Eq. 3)
|
|
(Eq. 4)
|
where ku and kf
represent the observed rate constants for the unfolding and refolding
reactions in various concentrations of the denaturant ([D]),
respectively. kuw and kfw
are the rate constants of unfolding and refolding extrapolated to zero
denaturant concentration. mu and
mf are slopes of the unfolding and refolding reactions.
Proteolytic Digestion Assay--
Digestion experiments were
carried out by incubating hFGF-1 under appropriate buffer conditions
with trypsin in a 1:50 ratio. The protease action was stopped by
heating the mixture (protein + trypsin) at 90 °C for 10 min. The
products of the protease reaction were analyzed by SDS-PAGE. The degree
of cleavage was measured by estimating the intensity of the band (on
SDS-PAGE) corresponding to hFGF-1 (remaining after trypsin digestion)
using a scanning densitometer. The intensity of the band corresponding
hFGF-1 not treated with the enzyme was considered as a control for
100% protection against trypsin action.
NMR Experiments--
All NMR experiments were carried out on a
Bruker DMX 600 MHz spectrometer at 20 °C. A 5 mm inverse probe with
a self-shielded z-gradient was used to obtain all gradient-enhanced
1H-15N HSQC spectra (23, 24). 15N
decoupling during acquisition were accomplished using the GARP sequence
(25). 2048 complex data points were collected in the 1H
dimension of the 1H-15N HSQC experiments. In
the indirect 15N dimension of the spectra, 512 complex data
points were collected. The HSQC spectra were recorded at 32 scans at
all concentrations of GdnHCl. The concentration of the protein sample
was 0.5 mM in 95% H2O and 5% D2O
(containing 100 mM phosphate and 100 mM of
ammonium sulfate). 15N chemical shifts were referenced
using the consensus ratio of 0.0101329118 (26). All spectra were
processed on a Silicon Graphics workstation using UXNMR and Aurelia software.
Hydrogen-Deuterium Exchange--
For hydrogen-deuterium
exchange, the hFGF-1 samples were rapidly exchanged by ultrafiltration
(on a Amicon set-up) in 100 mM phosphate buffer (containing
100 mM of ammonium sulfate) prepared in 99.9%
D2O at 5 °C. Hydrogen-deuterium exchange was monitored by collecting 1H-15N HSQC spectra with 512 points in the t1 (evolution period) and 256 points in the t2 (detection period).
 |
RESULTS AND DISCUSSION |
GdnHCl-induced Unfolding of hFGF-1 Is Not a Two-state
Process--
The fluorescence spectrum of hFGF-1 is dominated by
tyrosine emission at 308 nm (20). The emission of the lone tryptophan emission at position 121 is quenched by the presence of proximate positive charges in the three-dimensional structure of the protein. This quenching effect is completely relieved in the unfolded state of
the protein, and the characteristic tryptophan emission is observed at
350 nm. These spectral features are ideal to monitor the conformational
changes induced in the protein during the unfolding process.
Unfolding of hFGF-1 monitored by steady state fluorescence reveals that
the protein is completely unfolded beyond 1.8 M GdnHCl (Fig. 2). The unfolding process is found
to be completely reversible. The GdnHCl-induced unfolding process
probed by the ellipticity changes at 228 nm (a composite CD signal
contributed by the secondary structural elements and optically active
aromatic groups in the protein) shows that hFGF-1 undergoes complete
unfolding only beyond 2.3 M GdnHCl (Fig. 2). The
Cm (concentration of the denaturant at which
50% of the protein is unfolded) values of the unfolding curves
obtained from the CD and the fluorescence experiments do not match,
implying that the GdnHCl-induced unfolding of hFGF-1 is not cooperative
and involves the formation of equilibrium intermediate(s). We
investigated the urea-induced unfolding of hFGF-1 to examine whether
the accumulation of the equilibrium intermediate(s) is dependent on the
nature of the denaturant (Fig. 3).
Surprisingly, unlike GdnHCl, the unfolding of hFGF-1 in urea is a
two-state process without the accumulation of intermediates. The
G(H2O) and Cm values
estimated from the urea unfolding curves monitored by the steady state
fluorescence and CD techniques are nearly identical
(Cm = ~2.3 M and
G(H2O) = ~3.25 kcal·mol). These
results could either be attributed to different unfolding pathways of hFGF-1 in urea and GdnHCl or to specific stabilization of the intermediate(s) in GdnHCl.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 2.
Urea induced unfolding of hFGF-1 monitored by
the changes in the 350/308 nm ratio ( ) and by the ellipticity
changes at 228 nm ( ). Both the optical techniques used yield
nearly an identical Cm value (~2.3
M), implying that hFGF-1 unfolds co-operatively in
urea.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Fraction of unfolded species at various
concentrations of GdnHCl, as monitored by the changes in the ratio of
350-308 nm fluorescence ( ) and by the 228 nm ellipticity changes
( ). It could be discerned that the unfolding curves obtained
using two different optical techniques (fluorescence and CD) do not
superimpose implying that the GdnHCl-induced unfolding of hFGF-1 does
not follow a two-state mechanism. The Cm values
for the GdnHCl-induced unfolding of hFGF-1 estimated from the CD and
the fluorescence experiments are 1.5 and 1.2 M,
respectively.
|
|
Unfolding of hFGF-1 Occurs in Two Stages--
Size exclusion
chromatography (SEC) is an useful technique to obtain information of
integral changes of molecule dimensions under denaturant effect (27,
28). This technique has been successfully used to identify and obtain
hydrodynamic data on stable intermediates in the folding/unfolding
pathway(s) of proteins (27). hFGF-1, in its native state, in 100 mM phosphate buffer (pH 7.2) containing 100 mM
each of sodium chloride and ammonium sulfate, elutes as a single peak
(retention time = 95.7 min) on the superdex-100 SEC-FPLC column.
The area under the peak corresponding to the native state of the
protein shows a progressive decrease with the increase in the GdnHCl
concentration (Fig. 4). In addition to
the native peak, two new peaks with retention times around 91 and 87 min are observed in the FPLC profiles of hFGF-1 collected in the GdnHCl
concentration range between 0.2 and 1.2 M (data not shown).
The population of the protein molecules representing the intermediate
peak (retention time = ~91 min) is maximum (~ 30%) at a
denaturant concentration of 1 M. A single prominent peak
(retention time = ~87 min) representing the protein in its unfolded state could be observed in the FPLC profile obtained beyond
1.5 M GdnHCl. The results of the SEC-FPLC experiment
clearly show that the GdnHCl unfolding of hFGF-1 proceeds
via the accumulation of a stable intermediate at around 1.0 M GdnHCl. The GdnHCl unfolding profile of hFGF-1 monitored
by the changes in the area under the native peak (retention time = ~95 min) is noncooperative and is found to occur in two stages. This
is evident from the biphasic nature of the denaturation curve (Fig. 4).
Multiphasic equilibrium unfolding profiles, monitored by FPLC, have
been reported in several proteins and are attributed to the formation
of intermediates in the time scales of the FPLC experiments (27, 28).
The first phase of unfolding (0-1.0 M GdnHCl) of hFGF-1
appears to represent an equilibrium transition between the native and
the intermediate state(s). The transition between the intermediate and
the unfolded state that occurs in the second phase of unfolding
(1.0-2.0 M GdnHCl) appears to be co-operative. This aspect
is evident from the steep slope and lesser number of data points in the
second phase of unfolding (Fig. 4). To judge the co-operativity of the transition from the intermediate to the unfolded state, we investigated the thermal unfolding of hFGF-1 (in 0.96 M GdnHCl) using
the fluorescence and CD spectroscopy (data not shown). The thermal
unfolding curves obtained using both the techniques were
superimposable, implying that the intermediate 219 transition is
co-operative and involves no intermediate(s). It is pertinent to
mention that because of the overlap of the FPLC peaks representing the
native, intermediate, and unfolded states of hFGF-1, the hydrodynamic
data pertaining to these conformational states could not be
quantitatively estimated accurately.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
GdnHCl-induced unfolding of hFGF monitored by
SEC-FPLC. The fraction of unfolded species formed was estimated
from the decrease in the area corresponding to the native peak
(retention time = ~95 min). It could be observed that the
denaturant -induced unfolding of the protein occurs in two phases. The
native (N) intermediate (I) transition
appears to occur in the first phase (0-1.0 M). The
intermediate unfolded (U) transition occurs
co-operatively in the second phase beyond 1.0 M
GdnHCl.
|
|
The Equilibrium Intermediate Resembles a Molten Globule-like
State--
ANS is a fluorescent dye that binds to hydrophobic regions
of proteins (19). This fluorescent probe has been immensely useful in
the identification of equilibrium intermediates such as the MGs. Molten
globule intermediates usually display a significant exposure of
hydrophobic cores to the solvent. Hence, ANS binds strongly to MG and
fluoresces intensely (29, 30). The dye generally exhibits weak binding
affinity to the native and unfolded states of proteins (29). The
binding affinity of hFGF-1 to ANS at various concentrations of GdnHCl
was monitored by the changes in the emission intensity at 520 nm (Fig.
5). The emission intensity of ANS upon
binding to the protein (hFGF-1) in 0.96 M GdnHCl is more
than twice that observed with the protein in its native state (Fig. 5).
Fluorescence spectra of ANS in the presence of the protein in 0.96 M GdnHCl reveals that the emission maxima of the dye blue shifts by about 30 nm (from 520 to 490 nm). Further increase in the
concentration of GdnHCl (to 0.96 M) results not only in the progressive decrease in the emission intensity but also is accompanied by a continuous red shift in the emission maxima. The protein in its
unfolded conformation(s) at and beyond 2 M GdnHCl exhibits weak binding to ANS (Fig. 5). Thus, results of the ANS binding and the
SEC-FPLC experiments analyzed in conjunction, clearly suggest a MG-like
intermediate state maximally accumulates at 0.96 M
GdnHCl.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Binding of ANS to hFGF-1 at various
concentrations of GdnHCl. It could be observed that the emission
changes at 520 nm are maximal at 0.96 M GdnHCl, implying
that protein accumulates maximally in the MG-like state at this
concentration (0.96 M) of the denaturant. The
inset depicts the emission spectra of the protein in the
native (N), intermediate (I), and unfolded
(U) states. Note that the formation of the I state is
accompanied by blue shift in the emission maxima.
|
|
The Intermediate State Has Higher Conformational
Flexibility--
Proteins in the MG state are proposed to have
considerable native secondary structural interactions and greater
flexibility of the side chains because of loss in some tertiary
structural interactions (19). In this context, one-dimensional proton
NMR spectra is expected to provide useful gross information on the conformational status of the equilibrium intermediate of hFGF-1 accumulated at 0.96 M GdnHCl. One-dimensional
1H NMR spectra of hFGF-1 (in its native state) is well
dispersed, which reflects the highly specific inter-residue
interactions within the compact folded state(s) of the protein (Fig.
6). These features are notably evident in
the fairly narrow line widths of resonances in the amide, aromatic
(10.0-7.0 ppm) and aliphatic ( 0.5 to 3.0 ppm) regions of the
one-dimensional 1H NMR spectrum of the protein in its
native state. The one-dimensional 1H NMR spectra of the
protein in 0 and 0.96 M GdnHCl states show an overall
similarity (Fig. 6). This appears reasonable as the concentration of
the native species (~70%) in 0.96 M predominates over
that of the intermediate state (~30%). However, a critical comparison of the two spectra reveals that the chemical shift dispersion of some of the resonances in the amide, aromatic and aliphatic regions of the spectrum of the protein in 0.96 M
GdnHCl is noticeably reduced (Fig. 6). These spectral features either imply a conformational exchange between the native and intermediate species or a free motion of some of the segments of the protein in the
intermediate state in 0.96 M GdnHCl (Fig. 6).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 6.
One-dimensional 1H NMR spectra of
hFGF-1 in 0, 0.96, and 2 M GdnHCl. It could be
observed that the spectrum of the protein in 0.96 M GdnHCl
shows prominent line broadening effects in some of the resonances
corresponding to the amide, aromatic (A), and aliphatic
(B) protons, which are characteristic of an MG-like state.
The concentration of the protein used was 0.5 mM.
|
|
Limited proteolytic digestion has been applied to investigate the
conformational flexibility of proteins (31, 32). The basic assumption
underlying this technique is that the proteolysis event is governed by
the stereochemistry and accessibility of the protein substrate as well
as the specificity of the proteolytic enzyme. Hence, even subtle
conformational changes in the protein could be successfully detected
using the limited proteolytic digestion technique. hFGF-1 possesses
many lysine and arginine residues in its sequence, and most of them are
concentrated in the C-terminal segment (spanning residues 105-140),
which constitutes the putative heparin binding site. Because the
cleavage sites for trypsin correspond to the carboxyl ends of lysine
and arginine residues, trypsin is an apt choice to monitor the
conformational differences that possibly exist between the native and
intermediate (identified at 0.96 M GdnHCl) states of
hFGF-1. In addition, the optimal pH for the proteolytic action of
trypsin (pH ~8.0) is closer to the pH at which the intermediate state
is realized (pH 7.2). Undigested hFGF-1 yields a band on SDS-PAGE,
which corresponds to a molecular mass of about 16 kDa (Fig.
7). The intensity of this band
(after Coomassie Blue staining) is used as a control to monitor the
degree of action of trypsin on the native and the intermediate states of hFGf-1. After 20 min of incubation, hFGF-1 (in its native state) with trypsin leaves about 45% of the protein uncleaved.
However, treatment of hFGF-1 in the intermediate (in 0.96 M
GdnHCl) state with trypsin shows that more than 75% of the 16-kDa band
is cleaved (Fig. 7). These results reveal that the protein in the
intermediate state as compared with the native state is more
susceptible to proteolysis implying increased conformational
flexibility of the protein in the intermediate state. It should be
mentioned that control experiments with bovine serum albumin revealed
that the presence of the denaturant (0.96 M GdnHCl) does
not have significant effect(s) on the cleavage efficiency of trypsin
(data not shown). In addition, comparison with the results of the
control experiments with bovine serum albumin showed that the higher
susceptibility of the protein (hFGF-1) to trypsin cleavage in 0.96 M GdnHCl is not a general denaturant effect.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Densitometry profile of the intensities of
the 16-kDa band (in SDS-PAGE) upon treatment with trypsin (bottom
panel). P, E, and D in
the bottom panel represent the protein (hFGF-1), enzyme
(trypsin), and 0.96 M denaturant (GdnHCl), respectively.
The concentration of the protein used was 0.5 mg/ml. The intensities of
the bands in the densitometric scan were normalized to the 16-kDa band
of the untreated hFGF-1 (lane 1) (top panel).
Lanes 2 and 3 in the SDS-PAGE (in the top
panel) represent the trypsin treated hFGF-1 in 0 and 0.96 M GdnHCl, respectively. The higher susceptibility of the
protein in 0.96 M GdnHCl (lane 3) to tryptic
cleavage is indicative of increased conformational flexibility of the
protein in the intermediate state.
|
|
Structural Changes in the Intermediate State of the
Protein--
NMR spectroscopy enables the study at the level of
individual amino acid residues during the folding/unfolding of a
protein (4, 33). Especially, the heteronuclear correlation experiments have been shown to be very sensitive because of high magnetization transfer between directly bonded nuclei (4). The 1H and
15N backbone chemical shifts of hFGF-1 have been recently
determined (34). This aspect enables us to use the
1H-15N heteronuclear single quantum coherence
(HSQC) technique to investigate the GdnHCl-induced unfolding of the
protein at high resolution.
The 1H-15N HSQC spectrum serves as a
fingerprint of the conformation state of a protein at each
concentration of GdnHCl. The HSQC spectrum of hFGF-1 in its native
state is well dispersed, which is characteristic for a folded protein
(Fig. 8). Increasing the GdnHCl
concentration below 0.6 M does not cause appreciable chemical shift changes in most of the cross-peaks in the HSQC spectra.
However, the cross-peaks corresponding to the residues belonging to the
N-terminal end of the hFGF-1 molecule exhibit significant chemical
shift perturbation (Fig. 8). At 0.96 M GdnHCl, at which the
intermediate state is maximally accumulated, the residues in the
C-terminal segment (spanning residues 95-140) are most prominently
perturbed (Fig. 8). Most of the residues that show significant chemical
shift changes or that are broadened appear to be those that are not
involved in the secondary structure formation. Majority of the residues
involved in the secondary structural interactions in the native state
do not show appreciable chemical shift changes or broadening (Fig. 8)
in 0.96 M GdnHCl. Among the 12 -strands comprising the
-barrel structure, the residues located in -strand IX and X
(residues 95-112) appear to be maximally affected in 0.96 M GdnHCl. The cross-peaks of most of these residues show an
average chemical shift difference exceeding 0.1 ppm. The cross-peaks of
some of the residues belonging to the C-terminal domain (residues
105-140) are broadened because of exchange (between the native and
intermediate species) or increased conformational fluctuations in the
intermediate state (Fig. 8). The HSQC spectra of hFGF-1 acquired beyond
1.3 M GdnHCl show limited chemical shift dispersion in the
1H dimension and are typical for an unfolded protein (Fig.
8). Because the concentration of the native species predominates at 0. 96 M GdnHCl, it is not possible to obtain a complete
description of the intermediate species. However, from the results
discussed above, it is reasonably clear that the -strands located in
the C-terminal segment are maximally perturbed in the intermediate state (realized in 0.96 M GdnHCl)

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 8.
A, 1H-15N HSQC
spectra of the hFGF-1 in 0, 0.96, and 2 M GdnHCl. The
cross-peaks that show a pronounced change in the chemical shift in 0.96 M GdnHCl have been boxed. B, weighted
average (of 15N and 1H) chemical shift
differences ( = 1H2 + ( 15N)0.2 of residues in the native and the intermediate
(in 0.96 M GdnHCl) states of hFGF-1. Profound changes in
the chemical shift values could be observed for residues located in the
C-terminal segment (residues 105-140) of the hFGF-1 molecule.
|
|
Hydrogen-deuterium exchange studies provide useful information on the
relative solvent accessibility of various amide protons in a protein
(35). These experiments derive advantage from the fact that the
hydrogen bonded amide protons exchange with solvent at several orders
of magnitude slower than those which are non-hydrogen-bonded. These
differences are a direct measure of the local rigidity or flexibility
in the protein molecule. In this context, we performed the
hydrogen-deuterium exchange experiments on the native, intermediate, and GdnHCl unfolded states of hFGF-1. Ninety cross-peaks could be
observed in the HSQC spectra of hFGF-1 obtained after 30 min of
equilibration of the protein in D2O (Fig.
9). Except for five residues (which are
located in the loop regions), most of the residues protected from
exchange are involved in secondary structure formation. In 0.96 M GdnHCl about 60 cross-peaks are protected (Fig. 9). The
additional amide protons exchanged out in the intermediate state mostly
correspond to the residues in the -strands IX, X, and XII located in
the C-terminal segment (residues spanning 95-140) of the hFGF-1
molecule. Interestingly, there is nearly perfect correlation between
the chemical shift perturbation data and the hydrogen-deuterium
exchange results; the residues that show significant chemical shift
perturbation correspond with those that get exchanged out in the
intermediate state at 0.96 M GdnHCl.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 9.
1H-15N HSQC spectra
of hFGF-1 in D2O at various concentrations of GdnHCl.
The additional cross-peaks that exchange out in 0.96 M
GdnHCl mostly correspond to the residues located in the -strands
VIII, IX, and X. Most of the other secondary structural interactions in
the protein appear to be unaffected in the intermediate state.
|
|
Accumulation of Kinetic Intermediates--
It would be interesting
to understand whether the intermediate identified in the GdnHCl-
induced equilibrium unfolding process of hFGF-1 also exists in the
kinetic refolding pathway of the protein. In this context, the kinetics
of the refolding and unfolding process of hFGF-1 were investigated.
Complete refolding of hFGF-1 from its denatured state in 4 M GdnHCl (monitored by the changes in the tryptophan
emission at 350 nm) occurs in a time span of 60 s (Fig.
10). Interestingly, the unfolding of
the protein in 2 M GdnHCl is very slow, and it takes more
than 20 min for complete unfolding of the protein. The unfolding and
refolding rates were measured as a function of the denaturant (GdnHCl)
concentration to produce a classical Chevron plot (36, 37). The
transition midpoint is observed around 1.3 M and agrees
closely with that estimated from the equilibrium unfolding data (Fig.
10). The refolding limb (between 0.2 and 1.4 M GdnHCl)
exhibits a prominent curvature below 1.0 M GdnHCl (Fig.
10). Such a type of "roll-over" in the Chevron plot is a clear
evidence that kinetic intermediate(s) accumulates at lower
concentration of GdnHCl (<1.2 M). These results suggest
that the equilibrium intermediate accumulated in 0.96 M
GdnHCl probably also exists in the kinetic refolding pathway of
hFGF-1.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 10.
A, stopped flow fluorescence
curve representing the changes in the tryptophan emission
during the refolding of hFGF-1. The residual of the two exponential fit
is indicated at the bottom of A. B,
semilogarithmic plot of the kinetics of folding and unfolding of hFGF-1
as a function of the GdnHCl concentration. The Chevron plot exhibits a
transition point around 1.3 M in close agreement with that
estimated from the equilibrium unfolding experiments. The refolding
limb of the Chevron plot shows a prominent roll-over at lower
concentrations of GdnHCl, implying the accumulation of kinetic
intermediate(s).
|
|
Significance of the Molten Globule-like Intermediate--
Molten
globules have been implicated in several physiological processes (19).
Proteins have been proposed to translocate across bio-membranes in
their molten globule states (38). In this background, identification
and characterization of a molten globule-like state in the unfolding
pathway of hFGF-1 bears significance. hFGF-1 lacks a conventional
signal sequence, and it has been demonstrated to translocate across
biomembranes when fused to the diphtheria toxin. Interestingly, this
translocation process is inhibited by the presence of heparin or other
polyanions, which stabilize the structure of hFGF-1 (39, 40). Thus, it
is envisaged that the translocation-competent hFGF-1 has a partially
folded molten globule-like state. Although the conditions used in this
study are far from those prevailing in the cell, the structure of the intermediate state is expected to share some common features with the
contemplated translocation-competent state. Detailed structural characterization of the intermediate state based on NOE analysis is
underway to obtain deeper insights into the structural interactions that come into play during the folding/unfolding of all -barrel proteins, in general.
 |
ACKNOWLEDGEMENT |
We thank Prof. Ing-ming Chiu for providing us
the hFGF-clone.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Fax: 886-35-711082;
E-mail: cyu@mx.nthu.edu.tw.
Published, JBC Papers in Press, August 18, 2000, DOI 10.1074/jbc.M005147200
 |
ABBREVIATIONS |
The abbreviations used are:
MG, molten globule;
hFGF-1, human acidic fibroblast growth factor;
GdnHCl, guanidinium
hydrochloride;
PAGE, polyacrylamide gel electrophoresis;
ANS, 1-anilinonapthalene 8-sulfonate;
FPLC, fast protein liquid
chromatography;
SEC, size exclusion chromatography;
HSQC, heteronuclear
single quantum coherence.
 |
REFERENCES |
| 1.
|
Dobson, C.,
and Karplus, M.
(1999)
Curr. Opin. Struct. Biol.
9,
92-101
|
| 2.
|
Kay, M. S.,
Ramos, C. H.,
and Baldwin, R. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2007-2012
|
| 3.
|
Park, S. H.,
O'Neal, K. T.,
and Roder, H.
(1997)
Biochemistry
47,
14277-14283
|
| 4.
|
Vam Mierlo, C. P. M.,
Vanpen O ever, J. M. P.,
and Steensma, E.
(2000)
Protein Sci.
9,
145-157
|
| 5.
|
Matthews, C. R.
(1993)
Annu. Rev. Biochem.
62,
652-683
|
| 6.
|
Ptitsyn, O. B.,
Pain, R. H.,
Semisotonov, G. V.,
Zerovnik, E.,
and Razgulyaev, O. I.
(1990)
FEBS Lett.
262,
20-24
|
| 7.
|
Liu, Z.,
Rizo, J.,
and Gierasch, L. M.
(1994)
Biochemistry
33,
134-142
|
| 8.
|
Mizuguchi, M.,
Masaki, K.,
Demura, M.,
and Nilta, K.
(2000)
J. Mol. Biol.
298,
985-995
|
| 9.
|
Kumar, T. K. S.,
Jayaraman, G.,
Lee, C. S.,
Sivaraman, T.,
Lin, W. Y.,
and Yu, C.
(1995)
Biochem. Cell Biol.
207,
536-543
|
| 10.
|
Dabora, J. M.,
Pelton, J. G.,
and Marqusee, S.
(1996)
J. Mol. Biol.
285,
279-291
|
| 11.
|
Ptitsyn, O. B.
(1992)
in
Protein Folding
(Creighton, T. E., ed)
, pp. 243-300, W. H. Freeman Co., New York
|
| 12.
|
Arai, M.,
and Kuwajima, K.
(2000)
Adv. Protein Chem.
53,
209-282
|
| 13.
|
Sivaraman, T.,
Kumar, T. K.,
Jayaraman, G.,
Han, C. C.,
and Yu, C.
(1997)
Biochemistry
321,
457-464
|
| 14.
|
Kumar, T. K. S.,
Subbiah, V.,
Ramakrishna, T.,
and Pandit, M. W.
(1994)
J. Biol. Chem.
269,
12620-12625
|
| 15.
|
Jones, S.,
Reader, J. S.,
Capaldi, A. P.,
Ashcroft, A. E.,
Kalverda, A. P.,
Smith, D. A.,
and Radford, S. E.
(2000)
Biochemistry
39,
5672-5682
|
| 16.
|
Carlsson, U.,
and Jonsson, B. H.
(1995)
Curr. Opin. Struct. Biol.
5,
482-487
|
| 17.
|
Capaldi, A. P.,
and Radford, S. E.
(1998)
Curr. Opin. Struct. Biol.
8,
86-92
|
| 18.
|
Ferguson, N.,
Capaldi, A. P.,
James, R.,
Kleanthous, C.,
and Radford, S. E.
(1999)
J. Mol. Biol.
286,
1997-1608
|
| 19.
|
Buchanan, S.
(1999)
Curr. Opin. Struct. Biol.
9,
455-461
|
| 20.
|
Lozano, R. M.,
Pineda-Lucena, A.,
Gonzalez, C.,
Jimenez, M. A.,
Cuevas, P.,
Redondo-Horcajo, M.,
Sanz, J. M.,
Rico, M.,
and Gimenez-Gallego, G.
(2000)
Biochemistry
39,
4982-4993
|
| 21.
|
Zhu, X.,
Komiya, H.,
Chirino, A.,
Faham, S.,
Fox, G. M.,
Arakawa, T.,
Hsu, B. T.,
and Rees, D. C.
(1991)
Science
251,
90-93
|
| 22.
|
Pineda-Lucena, A.,
Jimenez, M. A.,
Lozano, R. M.,
Nieto, J. L.,
Santoro, J.,
Rico, M.,
and Gimenez-Gallego, G.
(1996)
J. Mol. Biol.
264,
162-178
|
| 23.
|
Palmer, A. G., III,
Cavanagh, J.,
Wright, P. E.,
and Rance, M.
(1991)
J. Magn. Reson.
93,
151-170
|
| 24.
|
Kay, L. E.,
Keifer, P.,
and Saarimen, T.
(1992)
J. Am. Chem. Soc.
114,
10663-10665
|
| 25.
|
Shaka, A. J.,
Barker, P. B.,
and Freeman, R.
(1985)
J. Magn. Reson.
64,
547-552
|
| 26.
|
Wishart, D. S.,
Bigami, C. G.,
Yao, J.,
Abidgaard, F.,
Dyson, H. J.,
Oldfield, E.,
Markley, J. L.,
and Sykes, B. D.
(1995)
I. Biomol. NMR
6,
135-140
|
| 27.
|
Uversky, V. N.
(1995)
Biochemistry
32,
13288-13298
|
| 28.
|
Uversky, V. N.,
Semisotonov, G. V.,
Pain, R. H.,
and Ptitsyn, O. B.
(1992)
FEBS Lett.
314,
89-93
|
| 29.
|
Semisotonov, G. V.,
Rodionova, N. A.,
Razgulyaev, O. I.,
Uversky, V. N.,
Gripas, A. F.,
and Gilmanshin, R. I.
(1991)
Biopolymers
31,
119-128
|
| 30.
|
Schonbrunner, N.,
Pappenberger, G.,
Scharf, M.,
Engels, J.,
and Kiefhaber, T.
(1997)
Biochemistry
36,
9057-9066
|
| 31.
|
Wang, L.,
and Kallenbach, N. R.
(1998)
Protein Sci.
7,
2360-2464
|
| 32.
|
Ellison, D.,
Hinton, J.,
Hussbard, S. J.,
and Beynon, R. J.
(1995)
Protein Sci.
4,
1337-1345
|
| 33.
|
Schulman, B. A.,
Kim, P. S.,
Dobson, C. M.,
and Redfield, C
(1997)
Natl. Struct. Biol.
6,
630-634
|
| 34.
|
Ogura, K.,
Nagata, K.,
Hatanaka, H.,
Habuchi, H.,
Kimata, K.,
Tati, S.,
Raveru, M. W.,
Jaye, M.,
Schlessinger, J.,
and Inagaki, F.
(1999)
J. Biomol. NMR
13,
11-24
|
| 35.
|
Bai, X.,
Sosnick, T. R.,
Mayne, L.,
and Englander, S. W.
(1995)
Science
269,
192-197
|
| 36.
|
Bhuyan, A. K.,
and Udgaonkar, J. B.
(1997)
Biochemistry
38,
9158-9168
|
| 37.
|
Parker, M. J.,
and Marqusee, S.
(1999)
J. Mol. Biol.
293,
1195-1210
|
| 38.
|
Bychkova, V. E.,
Pain, R. H.,
and Ptitsyn, O. B.
(1998)
FEBS Lett.
238,
231-234
|
| 39.
|
Sanz, J. M.,
and Gimenez-Gallego, G.
(1997)
Eur. J. Biochem.
246,
328-335
|
| 40.
|
Mach, H.,
and Middaugh, C. R.
(1995)
Biochemistry
34,
9913-9920
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Fukunaga, E. Nishimoto, T. Otosu, Y. Murakami, and S. Yamashita
The Unfolding of {alpha}-Momorcharin Proceeds Through the Compact Folded Intermediate
J. Biochem.,
October 1, 2008;
144(4):
457 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fukunaga, E. Nishimoto, K. Yamashita, T. Otosu, and S. Yamashita
The Partially Unfolded State of {beta}-Momorcharin Characterized with Steady-state and Time-resolved Fluorescence Studies
J. Biochem.,
January 1, 2007;
141(1):
9 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mandinova, R. Soldi, I. Graziani, C. Bagala, S. Bellum, M. Landriscina, F. Tarantini, I. Prudovsky, and T. Maciag
S100A13 mediates the copper-dependent stress-induced release of IL-1{alpha} from both human U937 and murine NIH 3T3 cells
J. Cell Sci.,
July 1, 2003;
116(13):
2687 - 2696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Srisailam, T. K. S. Kumar, D. Rajalingam, K. M. Kathir, H.-S. Sheu, F.-J. Jan, P.-C. Chao, and C. Yu
Amyloid-like Fibril Formation in an All beta -Barrel Protein. PARTIALLY STRUCTURED INTERMEDIATE STATE(S) IS A PRECURSOR FOR FIBRIL FORMATION
J. Biol. Chem.,
May 9, 2003;
278(20):
17701 - 17709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Inui, T. Ohkubo, M. Emi, D. Irikura, O. Hayaishi, and Y. Urade
Characterization of the Unfolding Process of Lipocalin-type Prostaglandin D Synthase
J. Biol. Chem.,
January 24, 2003;
278(5):
2845 - 2852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Srimathi, T. K. S. Kumar, Y.-h. Chi, I.-M. Chiu, and C. Yu
Characterization of the Structure and Dynamics of a Near-native Equilibrium Intermediate in the Unfolding Pathway of an All beta -Barrel Protein
J. Biol. Chem.,
November 27, 2002;
277(49):
47507 - 47516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Arunkumar, S. Srisailam, T. K. S. Kumar, K. M. Kathir, Y.-H. Chi, H.-M. Wang, G.-G. Chang, I. M. Chiu, and C. Yu
Structure and Stability of an Acidic Fibroblast Growth Factor from Notophthalmus viridescens
J. Biol. Chem.,
November 22, 2002;
277(48):
46424 - 46432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Chi, T. K. S. Kumar, I.-M. Chiu, and C. Yu
Identification of Rare Partially Unfolded States in Equilibrium with the Native Conformation in an All beta -Barrel Protein
J. Biol. Chem.,
September 13, 2002;
277(38):
34941 - 34948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Srisailam, H.-M. Wang, T. K. S. Kumar, D. Rajalingam, V. Sivaraja, H.-S. Sheu, Y.-C. Chang, and C. Yu
Amyloid-like Fibril Formation in an All beta -Barrel Protein Involves the Formation of Partially Structured Intermediate(s)
J. Biol. Chem.,
May 17, 2002;
277(21):
19027 - 19036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Sung, H.-D. Hong, C. Cheong, J. H. Kim, J. M. Cho, Y.-R. Kim, and W. Lee
Folding and Stability of Sweet Protein Single-chain Monellin. AN INSIGHT TO PROTEIN ENGINEERING
J. Biol. Chem.,
November 16, 2001;
276(47):
44229 - 44238.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|